Patents by Inventor Bice Perussia

Bice Perussia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070104680
    Abstract: This application relates to antibodies reactive with a novel homogenous human cytokine, Natural Killer Stimulator Factor (NKSF), having the ability to induce the production of gamia interferon in vitro in human peripheral blood lymphocytes, and a pharmaceutical preparation containing such antibodies.
    Type: Application
    Filed: August 16, 2006
    Publication date: May 10, 2007
    Inventors: Giorgio Trinchieri, Bice Perussia, Stanley Wolf, Steven Clark, Gordon Wong, Rodney Hewick, Michiko Kobayashi
  • Patent number: 7122633
    Abstract: This application relates to antibodies reactive with a novel homogenous human cytokine, Natural Killer Stimulator Factor (NKSF), having the ability to induce the production of gamma interferon in vitro in human peripheral blood lymphocytes, and a pharmaceutical preparation containing such antibodies.
    Type: Grant
    Filed: February 5, 2003
    Date of Patent: October 17, 2006
    Assignees: The Wistar Institute, Wyeth
    Inventors: Giorgio Trinchieri, Bice Perussia, Stanley F. Wolf, Steven C. Clark, Gordon G. Wong, Rodney Hewick, Michiko Kobayashi
  • Patent number: 7038031
    Abstract: The present invention provides DNA encoding an Fc?RIII(CDl6) receptor protein expressed on NK cells. The invention also provides a stable cell line expressing the Fc?RIII(CDl6) from NK cells. Further provided is a method for determining the presence of HIV-enhancing antibodies and a method for treating an HIV-infected subject.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: May 2, 2006
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Jeffrey V. Ravetch, Bice Perussia
  • Publication number: 20040044186
    Abstract: This application relates to antibodies reactive with a novel homogenous human cytokine, Natural Killer Stimulator Factor (NKSF), having the ability to induce the production of gamma interferon in vitro in human peripheral blood lymphocytes, and a pharmaceutical preparation containing such antibodies.
    Type: Application
    Filed: February 5, 2003
    Publication date: March 4, 2004
    Applicant: Wyeth and The Wistar Institute
    Inventors: Giorgio Trinchieri, Bice Perussia, Stanley F. Wolf, Steven C. Clark, Gordon G. Wong, Rodney Hewick, Michiko Kobayashi
  • Patent number: 6555658
    Abstract: This application relates to antibodies reactive with a novel homogenous human cytokine, Natural Killer Stimulator Factor (NKSF), having the ability to induce the production of gamma interferon in vitro in human peripheral blood lymphocytes, and a pharmaceutical preparation containing such antibodies.
    Type: Grant
    Filed: August 9, 2001
    Date of Patent: April 29, 2003
    Assignees: Wyeth, The Wistar Institute
    Inventors: Giorgio Trinchieri, Bice Perussia, Steven C. Clark, Gordon G. Wong, Rodney Hewick, Michiko Kobayashi
  • Publication number: 20020137898
    Abstract: A novel homogeneous human cytokine, Natural Killer Stimulatory Factor, having the ability to induce the production of gamma interferon in vitro in human peripheral blood lymphocytes, and a pharmaceutical preparation containing it.
    Type: Application
    Filed: August 9, 2001
    Publication date: September 26, 2002
    Inventors: Giorgio Trinchieri, Bice Perussia, Steven C. Clark, Gordon G. Wong, Rondey Hewick, Michiko Kobayashi
  • Patent number: 6300478
    Abstract: Antibodies reactive with a novel homogeneous human cytokine, Natural Killer Stimulatory Factor, (NKSF), NKSF having the ability to induce the production of gamma interferon in vitro in human peripheral blood lymphocytes, and a pharmaceutical preparation containing such antibodies.
    Type: Grant
    Filed: June 4, 1999
    Date of Patent: October 9, 2001
    Assignee: Genetics Institute, Inc.
    Inventors: Giorgio Trinchieri, Bice Perussia, Steven C. Clark, Gordon G. Wong, Rodney Hewick, Michiko Kobayashi
  • Patent number: 5811523
    Abstract: A novel homogeneous human cytokine, Natural Killer Stimulatory Factor, having the ability to induce the production of gamma interferon in vitro in human peripheral blood lymphocytes, and a pharmaceutical preparation containing it.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: September 22, 1998
    Inventors: Giorgio Trinchieri, Bice Perussia, Steven C. Clark, Gordon G. Wong, Rodney Hewick, Michiko Kobayashi, Stanley F. Wolf
  • Patent number: 5648072
    Abstract: Methods of inducing gamma interferon production and stimulating lymphocyte populations using Natural Killer Stimulatory Factor (NKSF) are disclosed.
    Type: Grant
    Filed: March 13, 1995
    Date of Patent: July 15, 1997
    Assignee: Genetics Institute, Inc.
    Inventors: Giorgio Trinchieri, Bice Perussia, Steven C. Clark, Michiko Kobayashi, Gordon G. Wong, Rodney Hewick, Stanley F. Wolf
  • Patent number: 5648467
    Abstract: A novel homogeneous human cytokine, Natural Killer Stimulatory Factor, having the ability to induce the production of gamma interferon in vitro in human peripheral blood lymphocytes, and a pharmaceutical preparation containing it.
    Type: Grant
    Filed: March 13, 1995
    Date of Patent: July 15, 1997
    Assignee: Genetics Institute, Inc.
    Inventors: Giorgio Trinchieri, Bice Perussia, Steven C. Clark, Gordon G. Wong, Rodney Hewick, Michiko Kobayashi, Stanley F. Wolf
  • Patent number: 5569454
    Abstract: Methods of treating an infection using Natural Killer Stimulatory Factor (NKSF) are disclosed.
    Type: Grant
    Filed: March 13, 1995
    Date of Patent: October 29, 1996
    Assignee: Genetics Institute, Inc.
    Inventors: Giorgio Trinchieri, Bice Perussia, Steven C. Clark, Gordon G. Wong, Rodney Hewick, Michiko Kobayashi, Stanley F. Wolf
  • Patent number: 5457038
    Abstract: A novel homogeneous human cytokine, Natural Killer Stimulatory Factor, having the ability to induce the production of gamma interferon in vitro in human peripheral blood lymphocytes, and a pharmaceutical preparation containing it.
    Type: Grant
    Filed: September 18, 1990
    Date of Patent: October 10, 1995
    Assignee: Genetics Institute, Inc.
    Inventors: Giorgio Trinchieri, Bice Perussia, Michiko Kobayashi, Steven C. Clark, Gordon G. Wong, Rodney Hewick